good news

2021-11-03

good news

Ocugen has added ~6.5% in the pre-market after its partner Bharat Biotech was granted the Emergency Use Listing (EUL) for its COVID-19 vaccine by the World Health Organization (WHO) on Wednesday.

Ocugen has partnered with Bharat Biotech to co-develop the vaccine for the U.S. market. Last week, the company said it requested FDA clearance to start a U.S.-based late-stage study for COVAXIN.

$Histogenics(OCGN)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":841754872,"tweetId":"841754872","gmtCreate":1635945509194,"gmtModify":1635949441651,"author":{"id":9000000000000699,"authorId":9000000000000699,"authorIdStr":"9000000000000699","name":"AugusMax","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":41,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"good news","extraTitle":"","html":"<html><head></head><body>good&nbsp;news Ocugen has&nbsp;added ~6.5%&nbsp;in the pre-market after its partner Bharat Biotech was granted the Emergency Use Listing (EUL) for its COVID-19 vaccine by the World Health Organization (WHO)&nbsp;on Wednesday. Ocugen has partnered with Bharat Biotech to co-develop the vaccine for the U.S. market. Last week, the company said it requested FDA clearance to start a U.S.-based&nbsp;late-stage study for COVAXIN. <a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a> </body></html>","htmlText":"<html><head></head><body>good&nbsp;news Ocugen has&nbsp;added ~6.5%&nbsp;in the pre-market after its partner Bharat Biotech was granted the Emergency Use Listing (EUL) for its COVID-19 vaccine by the World Health Organization (WHO)&nbsp;on Wednesday. Ocugen has partnered with Bharat Biotech to co-develop the vaccine for the U.S. market. Last week, the company said it requested FDA clearance to start a U.S.-based&nbsp;late-stage study for COVAXIN. <a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a> </body></html>","text":"good news Ocugen has added ~6.5% in the pre-market after its partner Bharat Biotech was granted the Emergency Use Listing (EUL) for its COVID-19 vaccine by the World Health Organization (WHO) on Wednesday. Ocugen has partnered with Bharat Biotech to co-develop the vaccine for the U.S. market. Last week, the company said it requested FDA clearance to start a U.S.-based late-stage study for COVAXIN. $Histogenics(OCGN)$","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/841754872","repostId":0,"isVote":1,"tweetType":1,"viewCount":1103,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["OCGN"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":356,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/841754872"}